Insider · CIK 0001550455

Bender James G.

Reports to the SEC for 2 companies · WOODLAND HILLS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001550455

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-03-11	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock Option (right to buy)A Award	Vice President - Manufacturing	AAward	+30K sh	—	—	30,000
2015-12-28	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock Option (right to buy)A Award	Vice President - Manufacturing	AAward	+27.6K sh	—	—	27,622
2015-09-30	IOVAIOVANCE BIOTHERAPEUTICS, INC.F Tax Payment	Vice President - Manufacturing	FTax Payment	−11.3K sh	$5.76	−$64.9K	88,726
2014-12-05	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock Option (right to buy)A Award	Vice President - Manufacturing	AAward	+46.7K sh	—	—	46,666
2014-01-06	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock OptionA Award	Vice President - Manufacturing	AAward	+100K sh	—	—	100,000
2014-01-06	IOVAIOVANCE BIOTHERAPEUTICS, INC.A Award	Vice President - Manufacturing	AAward	+100K sh	—	—	100,000
2013-08-29	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−900 sh	$3.00	−$2,700	100
2013-08-28	IMUCEOM Pharmaceutical Holdings, Inc.M Exercise/Conversion	VP, Product Development & Mfg.	MExercise/Conversion	+20K sh	$0.95	+$19K	20,679
2013-08-28	IMUCEOM Pharmaceutical Holdings, Inc.F Tax Payment	VP, Product Development & Mfg.	FTax Payment	−6,376 sh	$2.98	−$19K	14,303
2013-08-28	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Product Development & Mfg.	MExercise/Conversion	−20K sh	—	—	0
2013-08-28	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−3,303 sh	$2.85	−$9,413.55	6,000
2013-08-28	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−5,000 sh	$2.88	−$14.4K	1,000
2013-08-28	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−5,000 sh	$2.84	−$14.2K	9,303
2013-03-07	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	VP, Product Development & Mfg.	AAward	−80K sh	—	—	80,000
2012-06-11	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	VP, Product Development & Mfg.	AAward	+75K sh	—	—	75,000
2012-06-01	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−1,500 sh	$3.59	−$5,385	6,179
2012-06-01	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−600 sh	$3.61	−$2,166	679
2012-06-01	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−1,500 sh	$3.59	−$5,385	6,379
2012-06-01	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−4,900 sh	$3.60	−$17.6K	1,479
2012-06-01	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−600 sh	$3.61	−$2,166	879
2012-06-01	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−4,900 sh	$3.60	−$17.6K	1,279
2012-05-31	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−6,800 sh	$3.92	−$26.7K	7,879
2012-05-31	IMUCEOM Pharmaceutical Holdings, Inc.S Sale	VP, Product Development & Mfg.	SSale	−200 sh	$3.94	−$788	7,679

Recent filings

Accepted (ET)
Mar 154
Lion Biotechnologies, Inc.0001250853-16-000132
SEC(opens sec.gov)
Dec 304
Lion Biotechnologies, Inc.0001250853-15-000108
SEC(opens sec.gov)
Dec 94
Lion Biotechnologies, Inc.0001250853-14-000141
SEC(opens sec.gov)
Jan 134
Lion Biotechnologies, Inc.0001250853-14-000015
SEC(opens sec.gov)
Aug 304
ImmunoCellular Therapeutics, Ltd.0001181431-13-047124
SEC(opens sec.gov)
Mar 114
Bender James G.0001181431-13-016067
SEC(opens sec.gov)
Feb 224/A
Bender James G.0001181431-13-011843
SEC(opens sec.gov)
Jul 314
Bender James G.0001250853-12-000063
SEC(opens sec.gov)
Jun 64
Bender James G.0001250853-12-000057
SEC(opens sec.gov)

Companies

Address

21900 BURBANK BOULEVARD, 3RD FLOOR

WOODLAND HILLS, CA, 91367